Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bowel lavage before fecal microbiota transplantation in irritable bowel syndrome
NL-OMON48544Recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Apr 2019
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Open-label trial of allogeneic fecal microbiota in irritable bowel syndrome (IBS) (2 arms), sponsored by Vrije University Medical Center. Primary endpoint: Level of donor microbiota engraftment. Started Apr 2019; status: recruiting.
02
Drugs
allogeneic fecal microbiota
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NL-OMON48544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48544.